Antiproliferative activity of shark cartilage with and without tumor necrosis factor-α in human umbilical vein endothelium

Pharmacotherapy

Volumn 16, Issue 2 I, 1996, Pages 237-244

  McGuire, Timothy R ^a,b   Kazakoff, Peter W ^a   Hoie, Eric B ^a   Fienhold, Margery A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TISSUE EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTROCYTOMA CELL; CARTILAGE; DOSE RESPONSE; DRUG ACTIVITY; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; NONHUMAN; SHARK; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ANIMALS; CARTILAGE; CELL CULTURE TECHNIQUES; CELL DIVISION; ENDOTHELIUM, VASCULAR; HUMANS; SHARKS; THYMIDINE; TISSUE EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0029920446     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235.442-7
2. Olander JV, Marasa JC, Kimes RC, et al. An assay measuring the stimulation of several types of bovine capillary endothelial cells by growth factor(s) derived from cultured human tumor cells. In Vitro 1982;18.99-107.
3. Vlodavsky I, Korner G, Ishai-Michaeli R, et al. Extracellular matrix-resident growth factors and enzymes, possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev 1990,9:203-26
4. Albo D, Arnoletti JP, Castiglioni A, et al. Thrombospondin and TGF-beta 1 promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 production and stimulate tumor cell attachment in vitro. Biochem Biophys Res Commun 1994;203.857-65
5. Herlyn M, Malkowicz SB. Regulatory pathways in tumor growth and invasion Lab Invest 1991;65:262-71
6. Lee A, Langer R. Shark cartilage contains inhibitors of tumor angiogenesis Science 1983;221:1185-7.
7. Oikawa T, Ashino-Fuse H, Shimamura M, Koide U, Iwaguchi T. A novel angiogenic (I) derived from Japanese shark cartilage. Cancer Lett 1990;51:181-6
8. Moses MA, Sudhalter J, Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 1990;248:1408-10
9. Carswell EA, Old LJ, Kassel RL. An endotoxin induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 1975;72:3666-72
10. Hieber U, Heim ME. Tumor necrosis factor for the treatment of malignancies. Oncology 1994;51:142-53.
11. Watanabe N, Niitsu Y, Umeno H, et al. Toxic effect of tumor necrosis factor on tumor vasculature in mice. Cancer Res 1988;48.2179-83
12. Kuzuya M, Kinsella JL. Induction of endothelial cell differentiation in vitro by fibroblast-derived soluble factors. Exp Cell Res 1994,215.310-18.
13. Rosenman SJ, Shrikant P, Dubb L, et al. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines J Immunol 1995,154:1888-99.
14. Jaffe EA, Nachman RI, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973;52:2745-56.
15. Fox SB, Gatter KC, Bicknell R, et al. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res 1993;53:4161-3.
16. Oikawa T, Hirotani K, Nakamura O, et al. A highly potent antiangiogenic activity of retinoids. Cancer Lett 1989;48:157-62.
17. Limanni A, Fleming T, Molina R, et al. Expression of genes for platelet-derived growth factor in adult human venous endothelium. A possible non-platelet-dependent cause of intimai hyperplasia in vein grafts and perianastomotic areas of vascular prostheses. J Vasc Surg 1988;7:10-20.
18. Billington DC. Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseases. Drug Des Discov 1991,8:3-35.
19. Sunderkotter C, Goebeler M, Schulze OK, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther 1991;51:195-216.
20. Billings PC, St. Clair WH, Maki PA, et al. Distribution of the Bowman Birk protease inhibitor in mice following oral administration. Cancer Lett 1992;62:191-7.
21. Lovegrove JA, Osman DL, Morgan JB, et al. Transfer of cow's milk β-lactoglobulin to human serum after a milk load. a pilot study. Gut 1993;34:203-7.